LEADD
LEADD performs goal-directed de novo molecular design to optimize molecular properties while enforcing synthetic feasibility.
Key Features:
- Fragment-based molecular graphs: Represents molecules as graphs composed of molecular fragments.
- Pairwise atom type compatibility rules: Uses knowledge-based pairwise atom type compatibility rules that constrain which bonds can form between fragments.
- Reference library extraction: Extracts fragments from a reference library of drug-like molecules to derive compatibility rules.
- Constraint-enforcing genetic operators: Implements novel genetic operators tailored to enforce compatibility constraints during evolution.
- Lamarckian evolutionary mechanism: Adapts reproductive behavior of molecules dynamically based on fitness within the objective function.
- Goal-directed optimization: Performs optimization of molecular properties under user-specified objective functions.
- Benchmarked performance: Demonstrated improved fitness and predicted synthetic accessibility relative to virtual screening and other evolutionary algorithms on standardized benchmark suites.
Scientific Applications:
- De novo drug discovery: Generates novel candidate molecules for drug discovery while prioritizing synthetic feasibility.
- Property optimization: Optimizes key molecular properties (fitness metrics) in a goal-directed manner.
- Synthetic accessibility-driven design: Produces molecules constrained by compatibility rules to enhance practical synthetic tractability.
- Method comparison and benchmarking: Serves as a comparative approach against virtual screening and other evolutionary algorithms using standardized benchmark suites.
Methodology:
Represents molecules as fragment-based graphs; derives knowledge-based pairwise atom type compatibility rules from a reference library of drug-like molecules; applies novel genetic operators that enforce compatibility constraints within an evolutionary algorithm incorporating a Lamarckian adaptation of reproductive behavior; evaluated on standardized benchmark suites against virtual screening and other evolutionary algorithms.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Linux
- Programming Languages:
- C++
- Added:
- 6/17/2022
- Last Updated:
- 6/17/2022
Operations
Data Inputs & Outputs
Backbone modelling
Publications
Kerstjens A, De Winter H. LEADD: Lamarckian evolutionary algorithm for de novo drug design. Journal of Cheminformatics. 2022;14(1). doi:10.1186/s13321-022-00582-y. PMID:35033209. PMCID:PMC8760751.